← Eichor
Study identifier: NCT06558474 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Optimization of Percutaenous Coronary Intervention With Liberal Use of Post-dilatation

Condition: Coronary Artery Disease  ·  Sponsor: Cathreine BV

PhaseN/A
Planned participants12000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

To achieve optimal long-term clinical results after percutaneous coronary intervention (PCI), adequate deployment of stents is essential. Thorough expansion of the stent and full apposition of stent struts against the vessel wall are determining factors for preventing stent thrombosis and restenosis for bare-metal as well as drug-eluting stents (DES). Standard coronary angiography is limited in assessing accurate vessel size and characterizing tissues and calcium load. Therefore, stent underexpansion frequently occurs after stent deployment. Post-dilation is often performed to achieve optimal stent expansion and reduce stent malapposition of stent struts, aiming to reduce stent thrombosis and restenosis both short term as long term. However, there are limited studies that have explored the effect of post-dilatation for stent optimization on clinical outcomes. As a result of the restricted evidence, there is no consensus whether post-dilatation should be used routinely in clinical practice and the extent to which post-dilatation is being utilized remains unclear. For this reason, the OPTIMIZE PCI was designed, a national registry-based quality improvement project to implement a liberal post-dilatation strategy in multiple PCI centers in the Netherlands. As part of the OPTIMIZE-PCI, a retrospective observational analysis will eventually be conducted to evaluate whether adopting this strategy has led to improved clinical outcomes after PCI in terms of major adverse cardiac eve…

This description comes directly from the study's public registry record.

Talk to the study team

K Teeuwen, MD, PhD  ·  + 31 040 239 9111  ·  koen.teeuwen@catharinaziekenhuis.nl

K.A.J. Beek, MD  ·  + 31 040 239 9111  ·  konrad.v.beek@catharinaziekenhuis.nl

Always discuss trial participation with your own doctor first.

Locations (1)

Catharina HospitalEindhoven, North Brabant, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06558474